NDARC’s Director, Professor Michael Farrell was the opening witness on the first day of public hearings for the NSW Special Commission of Inquiry into the Drug “Ice”.
This presentation was given by Dr Amy Peacock at the VI International Conference on Novel Psychoactive Substances, 8-9 April 2019, Maastricht, Netherlands.
In this presentation, Caroline Salom (Research Fellow for the Institute for Social Science Research and Queensland Coordinator, Drug Trends) talks through the Queensland results for the 2018 Illici
Dr Amy Peacock presented at a public meeting on Thursday 31st January in Sydney organised by the Therapeutic Goods Administration (TGA) to consult on regulatory options for appropriate access and s
Jodie Grigg presented key findings from the 2018 Western Australia Ecstasy and Related Drugs Reporting System interviews as part of a National Drug Research Institute public seminar on Thursday, 28
James Fetherston presented key findings from the 2018 Western Australia Illicit Drug Reporting System interviews as part of a National Drug Research Institute public seminar on Thursday, 28 Fe
In this presentation, A/Prof Raimondo Bruno (School of Medicine, University of Tasmania), discusses existing knowledge around synthetic cannabinoids and presents findings from the 2018 national Ill
This webinar looks at the use of opioid agonist treatment, primarily methadone and buprenorphine, for the treatment of pharmaceutical opioid dependence.
Presented at the NDARC Annual Symposium, Sydney, 28 August, 2012.
Professor Alison Ritter, director of the Drug Policy Modelling Program at NDARC, co-hosted a webinar on the current policy landscape and future opportunities for campaigning on drug law reform with